Politeknik Metal, 2026 yฤฑlฤฑnda gerรงekleลmesi รถngรถrรผlen yaygฤฑn ve sรผreklilik arz eden iliลkili taraf iลlemlerine dair Yรถnetim Kurulu raporunu aรงฤฑkladฤฑ. Rapor, Sermaye Piyasasฤฑ Kurulu’nun Kurumsal Yรถnetim Tebliฤi II.17.1 kapsamฤฑnda oluลturuldu.
ฤฐliลkili taraf iลlemlerinin detaylarฤฑ
Politeknik Metal’in iliลkili taraflarฤฑ olan Coventya Kimya San. ve Tic. A.ล., MacDermid Performance Solutions Kimyasal Sanayi ve Ticaret A.ล., Alent Enthone Chemistry (Shanghai) Co. Ltd. ve MacDermid Incorporated ile yapฤฑlan iลlemlerin, 2026 yฤฑlฤฑ iรงerisindeki toplam tutarฤฑnฤฑn, alฤฑล iลlemlerinde satฤฑลlarฤฑn maliyetine, satฤฑล iลlemlerinde ise hasฤฑlat tutarฤฑna oranฤฑnฤฑn %10’u aลabileceฤi รถngรถrรผlรผyor.
Sermaye Piyasasฤฑ Kurulu yรถnetimi
ลirket Yรถnetim Kurulu, Sermaye Piyasasฤฑ Kurulu’nun ilgili tebliฤi gereฤi hazฤฑrlanan rapor kapsamฤฑnda, sรถz konusu iลlemlerin piyasa koลullarฤฑ รงerรงevesinde ve ลirket menfaatleri doฤrultusunda tespit edileceฤini belirtti.
| ฤฐliลkili Taraf ฤฐลlemleri | |
| Yapฤฑlan Aรงฤฑklama Gรผncelleme mi? | Hayฤฑr (No) |
| Yapฤฑlan Aรงฤฑklama Dรผzeltme mi? | Hayฤฑr (No) |
| Konuya ฤฐliลkin Daha รnce Yapฤฑlan Aรงฤฑklamanฤฑn Tarihi | – |
| Yapฤฑlan Aรงฤฑklama Ertelenmiล Bir Aรงฤฑklama mฤฑ? | Hayฤฑr (No) |
| Bildirim ฤฐรงeriฤi | |
| Aรงฤฑklamalar | |
Sermaye Piyasasฤฑ Kurulu'nun 3 Ocak 2014 tarih ve 28871 sayฤฑlฤฑ Resmi Gazete'de yayฤฑmlanarak yรผrรผrlรผฤe giren II.17.1 sayฤฑlฤฑ "Kurumsal Yรถnetim Tebliฤi"nin 10. Maddesi hรผkmรผ gereฤince, 2026 faaliyet yฤฑlฤฑnda gerรงekleลmesi รถngรถrรผlen "Yaygฤฑn ve Sรผreklilik Arz Eden ฤฐliลkili Taraf ฤฐลlemleri"nin uygunluฤunun deฤerlendirilmesi amacฤฑyla 24.06.2026 tarihli rapor Yรถnetim Kurulu tarafฤฑndan hazฤฑrlanmฤฑลtฤฑr. Raporun sonuรง bรถlรผmรผ aลaฤฤฑda bilgilerinize sunulmuลtur.2026 Faaliyet Yฤฑlฤฑ Yaygฤฑn ve Sรผreklilik Arz Eden ฤฐliลkili Taraf ฤฐลlemlerine ฤฐliลkin Raporun Sonuรง Bรถlรผmรผ:ลirketimizin yaygฤฑn ve sรผreklilik arz eden iliลkili taraf iลlemleri kapsamฤฑnda ลirket iliลkili taraflarฤฑ olan;- Coventya Kimya San.ve Tic.A.ล.- MacDermid Performance Solutions Kimyasal Sanayi ve Ticaret A.ล.- Alent Enthone Chemistry (Shanghai) Co Ltd.- MacDermid Incorporated. ile yapฤฑlan iลlemlerin, 2026 yฤฑlฤฑ dรถnemi iรงerisindeki toplam tutarฤฑnฤฑn, alฤฑล iลlemlerinde kamuya aรงฤฑklanan son yฤฑllฤฑk finansal tablolara gรถre oluลan satฤฑลlarฤฑn maliyetine olan oranฤฑnฤฑn, satฤฑล iลlemlerinde ise kamuya aรงฤฑklanan son yฤฑllฤฑk finansal tablolara gรถre oluลan hasฤฑlat tutarฤฑna olan oranฤฑnฤฑn %10'unu aลabileceฤi รถngรถrรผlmektedir. Bu nedenle, ลirket Yรถnetim Kurulu tarafฤฑndan, Sermaye Piyasasฤฑ Kurulu'nun 03.01.2014 tarih ve 28871 sayฤฑlฤฑ Resmi Gazete'de yayฤฑmladฤฑฤฤฑ (II-17.1) sayฤฑlฤฑ Kurumsal Yรถnetim Tebliฤi'nin 10'uncu maddesi uyarฤฑnca, "2026 Faaliyet Yฤฑlฤฑ Yaygฤฑn ve Sรผreklilik Arz Eden ฤฐliลkili Taraf ฤฐลlemlerine ฤฐliลkin Yรถnetim Kurulu Raporu" hazฤฑrlanmฤฑลtฤฑr. Sรถz konusu Rapor uyarฤฑnca, anฤฑlan iลlemlerin ลartlarฤฑ, ลirket menfaatleri doฤrultusunda piyasa koลullarฤฑ รงerรงevesinde tespit edilecek ve uygulanan kar marjlarฤฑ, ลirket'in faaliyet alanฤฑ dikkate alฤฑnarak gerรงekleลtirilecektir. In accordance with Article 10 of the Communiquรฉ on Corporate Governance No. II-17.1, which entered into force upon its publication in the Official Gazette dated 3 January 2014 and numbered 28871 by the Capital Markets Board, the Board of Directors has prepared a report dated 24 June 2026 to evaluate the appropriateness of the "Common and Continuous Related Party Transactions" projected to take place during the 2026 fiscal year. The conclusion section of the report is presented below for your information. Conclusion Section of the Report on the Projected Common and Continuous Related Party Transactions for the 2026 Fiscal Year:Within the scope of our Company's recurring and continuous related party transactions, it is anticipated that the total transaction value in 2026 with the following related parties:- Coventya Kimya San. ve Tic. A.ล.- MacDermid Performance Solutions Kimyasal Sanayi ve Ticaret A.ล.- Alent Enthone Chemistry (Shanghai) Co. Ltd.- MacDermid Incorporatedmay exceed 10% of the cost of sales for purchase transactions, and 10% of the revenue for sales transactions, based on the most recently disclosed annual financial statements. Accordingly, the Company's Board of Directors has prepared the "Board of Directors Report on Recurring and Continuous Related Party Transactions for the 2026 Fiscal Year" in compliance with Article 10 of the Corporate Governance Communiquรฉ (II-17.1), published in the Official Gazette No. 28871 dated January 3, 2014 by the Capital Markets Board. Pursuant to this Report, the terms of the aforementioned transactions will be determined in line with prevailing market conditions and the best interests of the Company, and the applied profit margns will be established by taking into account the Company's field of activity. This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure statement, the Turkish version shall prevail. | |
